HSP90B1 and neoplasm: Elevated expression of GRP94 correlates with the aggressiveness of numerous other tumors, including esophageal (91), gastric (92), and pancreatic cancers (93) as well as oral carcinoma (94) and glioblastoma (95), indicating that GRP94 plays a tumor-promoting role in many different cancers.